Growth Metrics

Travere Therapeutics (TVTX) Profit After Tax Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 65.80%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 17.05%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -290.15%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 59.59%
7 Evaxion A 64.16 Bn 64.14 Bn - -129.68%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,228.66%
10 Travere Therapeutics 4.34 Bn 4.26 Bn 102.38 Mn 10.00%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10.00%
Dec 31, 2025 63.52%
Sep 30, 2025 146.95%
Jun 30, 2025 81.88%
Mar 31, 2025 69.70%
Dec 31, 2024 33.16%
Sep 30, 2024 -136.32%
Jun 30, 2024 30.93%
Mar 31, 2024 -57.60%
Dec 31, 2023 -5.30%
Sep 30, 2023 279.31%
Jun 30, 2023 -52.06%
Mar 31, 2023 -5.61%
Dec 31, 2022 -66.05%
Sep 30, 2022 -135.87%
Jun 30, 2022 -71.82%
Mar 31, 2022 -51.76%
Dec 31, 2021 57.60%
Sep 30, 2021 -58.05%
Jun 30, 2021 -49.65%
Mar 31, 2021 -6,766.71%
Dec 31, 2020 -301.94%
Sep 30, 2020 38.20%
Jun 30, 2020 32.64%
Mar 31, 2020 101.97%
Dec 31, 2019 -305.89%
Sep 30, 2019 33.07%
Jun 30, 2019 -73.32%
Mar 31, 2019 -122.97%
Dec 31, 2018 57.69%
Sep 30, 2018 -206.37%
Jun 30, 2018 -68.79%
Mar 31, 2018 -65.72%
Dec 31, 2017 -104.79%
Sep 30, 2017 52.05%
Jun 30, 2017 1.30%
Mar 31, 2017 -198.88%
Dec 31, 2016 -248.44%
Sep 30, 2016 -135.15%
Jun 30, 2016 47.49%
Mar 31, 2016 -71.72%
Dec 31, 2015 91.49%
Sep 30, 2015 687.20%
Jun 30, 2015 -316.24%
Mar 31, 2015 152.36%
Dec 31, 2014 -130.52%
Sep 30, 2014 -49.69%
Jun 30, 2014 329.05%
Mar 31, 2014 -1,497.13%
Nov 30, 2012 -4.06%
Aug 31, 2012 100.00%